KLS:7113
Top Glove Corporation Bhd. · KLS · Healthcare · MYR · FY for 2026
Figures on this page computed 2026-11-08 12:05 UTC
Last close
n/aMYR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
25.1xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
- Computed from the filing for 2026
7.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
7.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
10.3%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.17Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
Growth is the furthest below its sector's middle: 0.32 against 0.47 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Sales0.78x
Its own average over 10 years, 5.41B.
- Profit0.25x
Its own average over 9 years, 1.25B.
- Free cash flow0.53x
Its own average over 10 years, 825.5M.
- Debt0.93x
Its own average over 10 years, 916.8M.
- Pricen/a
Its own average over 0 years. Market data
Profit is furthest from its own average, at 0.25 times.
The filed years, as a table
10Each line is 100 at 2017-08-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2017-08-31 | 100.0 | 100.0 | 100.0 |
| 2018-08-31 | 123.6 | 132.2 | 102.1 |
| 2019-08-31 | 140.8 | 111.0 | 106.0 |
| 2020-08-31 | 212.3 | 541.2 | 107.4 |
| 2021-08-31 | 479.9 | 2,362.3 | 107.0 |
| 2022-08-31 | 163.5 | 68.7 | 106.5 |
| 2023-08-31 | 66.2 | n/a | 106.5 |
| 2024-08-31 | 73.8 | -19.7 | 106.5 |
| 2025-08-31 | 102.4 | 32.1 | 106.6 |
| 2026-08-31 | 124.1 | 93.7 | 106.6 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- MYR
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- MYR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- MYR
Figures behind the shape
Growth
-23.7%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate-23.7%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
Five-year EPS growth rate-47.5%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
One-year change in net income192.4%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
Returns on capital
7.6%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital7.6%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on equity6.2%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on assets4.6%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Margins
9.6%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin9.6%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Operating margin9.9%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Net margin7.3%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Free cash flow margin10.3%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Price
25.1xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings25.1x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
- Computed from the filing for 2026
Price to book1.6x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
- Computed from the filing for 2026
- computed
- Computed from the filing for 2026
EV to EBITDA11.3x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Price to sales ratio1.8x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
Safety
0.17safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity0.17
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Current ratio2.96
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Interest coverage11.8x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Altman Z-Score4.78
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
What it pays out
12.5%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
Payout ratio12.5%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Dividend cover ratio11.3x
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.